Skip to main content
. 2017 Sep 11;177(11):1680–1682. doi: 10.1001/jamainternmed.2017.3631

Table 2. Medicare Part D Utilization for Frequent Repository Corticotropin Injection Prescribers Relative to Their Specialty Peers (2014)a.

Rheumatology Neurology Nephrology Specialty Totalb All FPs,
(n = 243)c
FPs
(n = 94)
IPs
(n = 4323)
FPs
(n = 55)
IPs
(n = 13 178)
FPs
(n = 54)
IPs
(n = 8030)
FPs
(n = 203)
IPs
(n = 25 531)
Spending, $
rACTH spending 90 893 473 88 987 094 41 915 298 41 036 176 32 179 323 31 504 401 164 988 094 161 527 671 197 667 746
rACTH pending per prescriber 966 952 20 585 762 096 3 114 595 913 3 923 812 749 6327 813 448
Other drug spending 115 389 913 2 496 839 483 163 485 548 5 805 530 003 26 563 026 2 135 182 185 305 438 486 10 437 551 671 349 329 447
Other drug spending per prescriber 1 227 552 577 571 2 972 465 440 547 491 908 265 901 1 504 623 408 819 1 437 195
Prescriptions, No.
rACTH prescriptions 2279 2065 1052 953 878 796 4209 3814 5042
rACTH prescriptions per prescriber 24 0.5 19 0.1 16 0.1 21 0.2 21
Other drug prescriptions 432 314 11 431 881 284 208 20 601 963 178 338 15 995 227 894 860 48 029 071 1 087 613
Other drug prescriptions per prescriber 4599 2644 5167 1563 3303 1992 4408 1881 4476
Beneficiaries, No.d
rACTH beneficiaries 532 547 392 403 270 277 1194 1227 1446
rACTH beneficiaries per prescriber 5.7 0.1 7.1 0.03 5.0 0.03 5.9 0.05 6.0
rACTH prescriptions per beneficiary 4.3 3.8 2.7 2.4 3.3 2.9 3.5 3.1 3.5
Other drug beneficiaries 41 242 1 236 676 21 726 2 394 249 14 329 1 524 306 77 297 5 155 231 91 444
Other drug beneficiaries per prescriber 439 286 395 182 265 190 381 202 376
Other drug prescriptions per beneficiary 10.5 9.2 13.1 8.6 12.4 10.5 11.6 9.3 11.9

Abbreviations: FP, frequent repository corticotropin prescriber; IP, infrequent repository corticotropin prescriber; rACTH, repository corticotropin.

a

Medicare Part D prescribers with more than 10 rACTH prescriptions.

b

Rheumatology, neurology, nephrology specialty total.

c

Includes 40 prescribers from other specialties.

d

Five beneficiaries imputed for suppressed values and assumes each beneficiary receives prescriptions from 1 prescriber.